Patent Assignment
Reel/Frame 058026/0001
Assignment of Assignor's Interest
Recorded: 2021-11-04
Pages: 8
Assignors
JONES, PHILIP
Executed: 2019-09-26
CROSS, JASON
Executed: 2019-09-26
BURKE, JASON
Executed: 2019-09-27
MCAFOOS, TIMOTHY
Executed: 2019-09-26
KANG, ZHIJUN
Executed: 2019-09-26
Assignee
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
210 WEST 7TH STREET, AUSTIN, TEXAS, 78701
Covered Property
(1)
Substituted Heterocyclic Inhibitors of PTPN11
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 4, 2021
From: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
To: NAVIRE PHARMA, INC.
Reel/Frame 058026/0021 →
Security Interest
Jan 17, 2024
From: CALCILYTIX THERAPEUTICS INC.; ADRENAS THERAPEUTICS INC.; PHOENIX TISSUE REPAIR, INC.; NAVIRE PHARMA, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066342/0154 →
Security Interest
Jan 19, 2024
From: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; THERAS, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066355/0126 →
Release of Security Interest in Patent Collateral
Mar 5, 2025
From: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; ML BIO SOLUTIONS INC.
Reel/Frame 070551/0095 →